Donor Simvastatin Treatment Is Safe and Might Improve Outcomes After Liver Transplantation: A Randomized Clinical Trial.
Transplantation
; 106(12): 2379-2390, 2022 12 01.
Article
in En
| MEDLINE
| ID: mdl-35862782
Full text:
1
Database:
MEDLINE
Main subject:
Liver Transplantation
/
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Type of study:
Clinical_trials
/
Observational_studies
Limits:
Adult
/
Humans
Language:
En
Journal:
Transplantation
Year:
2022
Type:
Article
Affiliation country:
Italy